Saltar al contenido
Merck

Pharmacokinetics of cefuroxime in porcine cortical and cancellous bone determined by microdialysis.

Antimicrobial agents and chemotherapy (2014-03-26)
Mikkel Tøttrup, Tore Forsingdal Hardlei, Michael Bendtsen, Mats Bue, Birgitte Brock, Kurt Fuursted, Kjeld Søballe, Hanne Birke-Sørensen
RESUMEN

Traditionally, the pharmacokinetics of antimicrobials in bone have been investigated using bone biopsy specimens, but this approach suffers from considerable methodological limitations. Consequently, new methods are needed. The objectives of this study were to assess the feasibility of microdialysis (MD) for measuring cefuroxime in bone and to obtain pharmacokinetic profiles for the same drug in porcine cortical and cancellous bone. The measurements were conducted in bone wax sealed and unsealed drill holes in cortical bone and in drill holes in cancellous bone and in subcutaneous tissue. As a reference, the free and total plasma concentrations were also measured. The animals received a bolus of 1,500 mg cefuroxime over 30 min. No significant differences were found between the key pharmacokinetic parameters for sealed and unsealed drill holes in cortical bone. The mean ± standard error of the mean area under the concentration-time curve (AUC) values from 0 to 5 h were 6,013 ± 1,339, 3,222 ± 1086, 2,232 ± 635, and 952 ± 290 min · μg/ml for free plasma, subcutaneous tissue, cancellous bone, and cortical bone, respectively (P < 0.01, analysis of variance). The AUC for cortical bone was also significantly different from that for cancellous bone (P = 0.04). This heterogeneous tissue distribution was also reflected in other key pharmacokinetic parameters. This study validates MD as a suitable method for measuring cefuroxime in bone. Cefuroxime penetration was impaired for all tissues, and bone may not be considered one distinct compartment.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Acetonitrilo, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Acetonitrilo, HPLC Plus, ≥99.9%
Sigma-Aldrich
Acetonitrilo, ACS reagent, ≥99.5%
Sigma-Aldrich
Acetonitrilo, anhydrous, 99.8%
Sigma-Aldrich
Acetonitrilo, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Acetonitrilo, suitable for HPLC-GC, ≥99.8% (GC)
Sigma-Aldrich
Acetonitrilo, biotech. grade, ≥99.93%
Sigma-Aldrich
Acetonitrilo, ReagentPlus®, 99%
Sigma-Aldrich
Acetonitrilo, HPLC Plus, ≥99.9%, poly-coated bottles
Sigma-Aldrich
Acetonitrilo solution, contains 0.1 % (v/v) formic acid, suitable for HPLC
Sigma-Aldrich
Acetonitrilo solution, contains 0.1 % (v/v) trifluoroacetic acid, suitable for HPLC
Sigma-Aldrich
Acetonitrilo, electronic grade, 99.999% trace metals basis
Sigma-Aldrich
Acetonitrilo, suitable for DNA synthesis, ≥99.9% (GC)
Supelco
Cefuroxime sodium salt
Supelco
Acetonitrilo, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Acetonitrilo, HPLC grade, ≥99.93%
Sigma-Aldrich
Acetonitrilo, ≥99.8%, suitable for HPLC
Supelco
Acetonitrilo, analytical standard
USP
Acetonitrilo solution, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Acetonitrilo, ≥99.8%, for residue analysis, JIS 300
Sigma-Aldrich
Acetonitrilo, JIS special grade, ≥99.5%
Sigma-Aldrich
Acetonitrilo, ≥99.5%, ACS reagent
Supelco
Acetonitrilo, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Acetonitrilo solution, contains 0.05 % (w/v) ammonium formate, 5 % (v/v) water, 0.1 % (v/v) formic acid, suitable for HPLC
USP
Cefuroxime sodium, United States Pharmacopeia (USP) Reference Standard
Supelco
Cefuroxime, VETRANAL®, analytical standard
Sigma-Aldrich
Acetonitrilo, SAJ first grade, ≥99.0%
Cefuroxime sodium, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Acetonitrilo, for chromatography
Sigma-Aldrich
Acetonitrilo, ≥99.8%, for residue analysis, JIS 1000